Select Medical Holdings Corporation (SEM) — Fair Value Analysis

Base-case fair value (P50): $19.30 · Current price: $16.52 · Verdict: Undervalued

The Verdict on SEM

Our Monte Carlo simulations indicate that SELECT MEDICAL HOLDINGS CORP (SEM) is currently Fairly Valued. With SEM trading at $16.52, our comprehensive analysis yields a median fair value (P50) of $19.30. This calculation suggests an implied +16.8% potential relative to its current trading level, positioning SEM in a neutral valuation zone based on a robust range of forward-looking scenarios. The thousands of simulated operational and market outcomes consistently converge on this $19.30 target, suggesting $16.52 accurately reflects the probabilistic intrinsic value derived from our models.

How SEM stacks up against peers

SEM's quality tier is currently assessed as "weak," reflecting specific operational and financial health metrics when benchmarked against broader market comparables. This "weak" designation influences the risk-reward dynamics and can shape the probability distribution around our $19.30. While the current valuation at $16.52 implies an +16.8% to our median fair value, this weaker quality assessment suggests that SEM might exhibit greater sensitivity to adverse market conditions or operational challenges, potentially impacting the consistency of achieving that $19.30 in various future states.

What this means for investors

Considering the "Fairly Valued" verdict and the +16.8% implied by our $19.30 relative to $16.52, SEM presents a balanced outlook based on our quantitative models. While there's a clear upward potential to our median target, the "weak" quality tier warrants attention, suggesting a higher degree of caution for investors primarily seeking robust operational health. This implies that while bull-case scenarios could drive prices above $19.30, downside risks might be more pronounced for SEM compared to higher-quality names. FairCurve's detailed Monte Carlo analysis provides the full spectrum of these possibilities. To access the complete bear and bull distribution and track SEM's dynamic fair value as new fundamentals are released, sign up for a free FairCurve account.

Frequently Asked Questions

Is SEM overvalued or undervalued right now?

Based on our Monte Carlo simulations, SEM is currently assessed as 'Fairly Valued'. The median fair value (P50) of $19.30 suggests an upside from its current price of $16.52.

What is the bear case and bull case for SEM?

The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of achieving upside scenarios, is available exclusively to users with a free FairCurve account. We do not provide specific dollar values for these cases publicly.

How does FairCurve calculate SEM's fair value?

FairCurve calculates SEM's fair value using proprietary Monte Carlo simulations, running thousands of forward-looking scenarios to determine a probabilistic range of intrinsic values. This robust methodology accounts for various market and operational uncertainties.

How can I track SEM's fair value as it changes?

You can add SEM to your free FairCurve watchlist to receive daily fair-value updates and instant re-valuation whenever new earnings or significant fundamental data are released. This ensures your analysis always reflects the latest market and company developments.